Bobo Donald E Jr's Form 4 filing
Edwards Lifesciences Corp (EW) · filed May 13, 2024
- Accession no.
- 0001225208-24-005980
- Filed
- May 13, 2024
- Trade date
- May 10-11, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $439.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bobo Donald E JrCIK 0001196661 | Officer (CVP,Strategy/Corp Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $45.28 | +$226,400 | 52,749.72 | Direct | |
| May 10, 2024 | Common Stock | SSaleDisposed | −5,000 | $87.81F2 | −$439,050 | 47,749.72 | Direct | |
| May 11, 2024 | Common Stock | FTax withholdingDisposed | −814 | $86.72 | −$70,590.08 | 46,935.72 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 65,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $87.415 to $88.050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.